AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD)

CUSIP: 03152W109

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
316,644,581
Total 13F shares
305,140,281
Share change
-5,124,130
Total reported value
$2,874,465,217
Put/Call ratio
110%
Price per share
$9.42
Number of holders
286
Value change
-$56,740,355
Number of buys
131
Number of sells
144

Security key

03152W109

Report period

Q4 2024

Institutions

286

Top holders

10

Top shareholders of FOLD - AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) as of Q4 2024

As of 31 Dec 2024, AMICUS THERAPEUTICS, INC. - Common Stock, par value $0.01 per share (FOLD) was held by 286 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 305,140,281 shares. The largest 10 holders included VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, CITADEL ADVISORS LLC, Palo Alto Investors LP, and JPMORGAN CHASE & CO. This page lists 289 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
289
Q4 2024 holders
286
Holder diff
-3
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .